Annual report pursuant to Section 13 and 15(d)

Notes Payable (Details Narrative)

Notes Payable (Details Narrative) - USD ($)											1 Months Ended		12 Months Ended
Notes Payable (Details Narrative) - USD ($)	Mar. 24, 2017	Mar. 21, 2017	Mar. 13, 2017	Feb. 02, 2017	Nov. 03, 2016	Sep. 15, 2016	Aug. 02, 2016	Mar. 31, 2016	Jun. 29, 2015	Feb. 02, 2015	Mar. 31, 2017	Aug. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Mar. 15, 2017	Jul. 19, 2016	Feb. 03, 2015
Consideration received								$ 5,000,000
Estimated value of accounts receivable								$ 8,700,000
Adjustment value of debt													$ 0	$ 1,500,000
Investment percentage													20.00%
Debt term								6 months
Repayment of debt								$ 500,000
Debt instrument description								All payments recovered from the accounts receivable up to $5.25 million, if paid in full within six months, or $5.5 million, if not paid in full within six months, and (iii) 20% of all payments of the accounts receivable in excess of amounts received in (i) and (ii). On March 31, 2017, to the extent that the counterparty has not been paid $6.0 million, the Company was required to pay the difference. Christopher Diamantes, a director of the Company, guaranteed the Company’s obligation.
Accrued expenses													$ 2,300,000
Due to related party													$ 7,300,000
Debt instrument periodic payment					$ 400,000
Debt instrument maturity date													May 30, 2018
Warrant to purchase common stock														55,092,381	2,056	42,478
Warrant exercise per share													$ 0.276
Stock options exercise price per share														$ 1,778.25
Loan outstanding
Alcimede LLC [Member]
Debt instrument extended due date							Feb. 02, 2018			Aug. 02, 2017
Debt instrument interest rate																	6.00%
Debt instrument maturity date										Feb. 02, 2016
Due from related party																	$ 3,000,000
Share based payment of exercised options granted									2,223
Stock options exercise price per share									$ 1,125.00
Loan outstanding									$ 2,500,000
Repayment of common stock												$ 300,000
Alcimede LLC [Member] \| April 1, 2018 [Member]
Loan outstanding													168,500
Mr Lagan [Member]
Repayment of debt											$ 50,000		110,000
TCA Debenture [Member]
Repayment of debt		$ 750,000
Debt instrument fee		150,000
Accrued and unpaid interest		$ 100,000		$ 400,000
Debt instrument maturity date		Jun. 27, 2017
TCA Debenture [Member] \| April 2017 Through September 2017 [Member]
Debt instrument periodic payment		$ 2,600,000
September 2016 Notes [Member]
Debt instrument maturity date						Mar. 15, 2017
Debt instrument conversion price						$ 112.50
Warrant to purchase common stock						4,444
Warrant exercise per share						$ 180.00
Warrant exchanged shares of common stock			26,667
Mr Diamantis [Member]
Estimated value of accounts receivable	$ 5,000,000
Investment percentage	20.00%
Repayment of debt													3,600,000
Debt instrument extended due date	Mar. 31, 2018
Debt instrument interest rate	40.00%
Debt instrument fee	$ 1,000,000
Due to related party													4,600,000
Mr Diamantis [Member] \| Notes Payable [Member]
Estimated value of accounts receivable	$ 500,000
Two Investor [Member] \| September 2016 Notes [Member]
Debt instrument face amount						$ 400,000
Stockholder [Member]
Due to related party													$ 75,000